Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Computed Tomography Market 

5.1. COVID-19 Landscape: Computed Tomography Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Computed Tomography Market, By Technology

8.1. Computed Tomography Market, by Technology, 2023-2032

8.1.1. High slice

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Mid slice

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Low slice

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. Cone beam

8.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Computed Tomography Market, By Application

9.1. Computed Tomography Market, by Application, 2023-2032

9.1.1. Neurology

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Orthopedics

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Oncology

9.1.3.1. Market Revenue and Forecast (2021-2032)

9.1.4. Oncology

9.1.4.1. Market Revenue and Forecast (2021-2032)

9.1.5. Respiratory

9.1.5.1. Market Revenue and Forecast (2021-2032)

9.1.5. Gastrointestinal

9.1.5.1. Market Revenue and Forecast (2021-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Computed Tomography Market, By Modality 

10.1. Computed Tomography Market, by Modality, 2023-2032

10.1.1. O arm

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. C arm

10.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Computed Tomography Market, By End-User 

11.1. Computed Tomography Market, by End-User, 2023-2032

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Ambulatory surgery centers

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Health clinics

11.1.3.1. Market Revenue and Forecast (2021-2032)

11.1.4. Diagnostics imaging centers

11.1.4.1. Market Revenue and Forecast (2021-2032)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Computed Tomography Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Technology (2021-2032)

12.1.2. Market Revenue and Forecast, by Application (2021-2032)

12.1.3. Market Revenue and Forecast, by Modality (2021-2032)

12.1.4. Market Revenue and Forecast, by End-User (2021-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Technology (2021-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2021-2032)

12.1.5.3. Market Revenue and Forecast, by Modality (2021-2032)

12.1.5.4. Market Revenue and Forecast, by End-User (2021-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Technology (2021-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2021-2032)

12.1.6.3. Market Revenue and Forecast, by Modality (2021-2032)

12.1.6.4. Market Revenue and Forecast, by End-User (2021-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Technology (2021-2032)

12.2.2. Market Revenue and Forecast, by Application (2021-2032)

12.2.3. Market Revenue and Forecast, by Modality (2021-2032)

12.2.4. Market Revenue and Forecast, by End-User (2021-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Technology (2021-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2021-2032)

12.2.5.3. Market Revenue and Forecast, by Modality (2021-2032)

12.2.5.4. Market Revenue and Forecast, by End-User (2021-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Technology (2021-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2021-2032)

12.2.6.3. Market Revenue and Forecast, by Modality (2021-2032)

12.2.6.4. Market Revenue and Forecast, by End-User (2021-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Technology (2021-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2021-2032)

12.2.7.3. Market Revenue and Forecast, by Modality (2021-2032)

12.2.7.4. Market Revenue and Forecast, by End-User (2021-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Technology (2021-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2021-2032)

12.2.8.3. Market Revenue and Forecast, by Modality (2021-2032)

12.2.8.4. Market Revenue and Forecast, by End-User (2021-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Technology (2021-2032)

12.3.2. Market Revenue and Forecast, by Application (2021-2032)

12.3.3. Market Revenue and Forecast, by Modality (2021-2032)

12.3.4. Market Revenue and Forecast, by End-User (2021-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Technology (2021-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2021-2032)

12.3.5.3. Market Revenue and Forecast, by Modality (2021-2032)

12.3.5.4. Market Revenue and Forecast, by End-User (2021-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Technology (2021-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2021-2032)

12.3.6.3. Market Revenue and Forecast, by Modality (2021-2032)

12.3.6.4. Market Revenue and Forecast, by End-User (2021-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Technology (2021-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2021-2032)

12.3.7.3. Market Revenue and Forecast, by Modality (2021-2032)

12.3.7.4. Market Revenue and Forecast, by End-User (2021-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Technology (2021-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2021-2032)

12.3.8.3. Market Revenue and Forecast, by Modality (2021-2032)

12.3.8.4. Market Revenue and Forecast, by End-User (2021-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Technology (2021-2032)

12.4.2. Market Revenue and Forecast, by Application (2021-2032)

12.4.3. Market Revenue and Forecast, by Modality (2021-2032)

12.4.4. Market Revenue and Forecast, by End-User (2021-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Technology (2021-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2021-2032)

12.4.5.3. Market Revenue and Forecast, by Modality (2021-2032)

12.4.5.4. Market Revenue and Forecast, by End-User (2021-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Technology (2021-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2021-2032)

12.4.6.3. Market Revenue and Forecast, by Modality (2021-2032)

12.4.6.4. Market Revenue and Forecast, by End-User (2021-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Technology (2021-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2021-2032)

12.4.7.3. Market Revenue and Forecast, by Modality (2021-2032)

12.4.7.4. Market Revenue and Forecast, by End-User (2021-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Technology (2021-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2021-2032)

12.4.8.3. Market Revenue and Forecast, by Modality (2021-2032)

12.4.8.4. Market Revenue and Forecast, by End-User (2021-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Technology (2021-2032)

12.5.2. Market Revenue and Forecast, by Application (2021-2032)

12.5.3. Market Revenue and Forecast, by Modality (2021-2032)

12.5.4. Market Revenue and Forecast, by End-User (2021-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Technology (2021-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2021-2032)

12.5.5.3. Market Revenue and Forecast, by Modality (2021-2032)

12.5.5.4. Market Revenue and Forecast, by End-User (2021-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Technology (2021-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2021-2032)

12.5.6.3. Market Revenue and Forecast, by Modality (2021-2032)

12.5.6.4. Market Revenue and Forecast, by End-User (2021-2032)

Chapter 13. Company Profiles

13.1. Fujifilm Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Planmeca Oy

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Carestream Health

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Canon Medical Systems corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Neusoft Medical Systems

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Koninklijke Philips

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Siemens Healthineers

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Hitachi, Ltd

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. GE Healthcare

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. NeuroLogica Corp

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms